NCT04349566View on ClinicalTrials.gov

Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2021

Conditions
Becker Muscular DystrophyMcArdle DiseaseLimb-Girdle Muscular Dystrophy Type 2
Trial Locations (1)

DK-2100

Neuromuscular Research Unit, 3342, Copenhagen

Sponsors
All Listed Sponsors
collaborator

Edgewise Therapeutics, Inc.

INDUSTRY

lead

Mads Peter Godtfeldt Stemmerik

OTHER